Scott W Lee

Title: Innovations by Scott W. Lee in Fluid Delivery Systems

Introduction

Scott W. Lee is an accomplished inventor based in Redlands, CA. He has made significant contributions to the field of fluid delivery systems, particularly in the management of insulin delivery devices. With a total of 2 patents, his work focuses on improving the efficacy and safety of insulin delivery for users.

Latest Patents

Scott W. Lee's latest patents include innovative methodologies for adjusting fluid delivery settings. One of his patents, titled "Determination of adjustments to fluid delivery settings," discloses techniques related to accessing insulin delivery data for users of insulin delivery devices. This patent emphasizes the analysis of insulin delivery data to generate updated insulin sensitivity factor (ISF) values, ultimately leading to recommendations for adjusting the ISF value of the device.

Another notable patent is "Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system." This invention involves a computer-based device that manages a dual-mode insulin infusion device, which can operate in either manual or automated closed-loop insulin delivery modes. The methodology analyzes closed-loop pump data to generate updated basal rate data, providing recommendations for adjusting manual-mode settings accordingly.

Career Highlights

Scott W. Lee is currently employed at Medtronic Minimed, Inc., where he continues to develop innovative solutions for insulin delivery systems. His work has been instrumental in enhancing the functionality and user experience of insulin infusion devices.

Collaborations

Throughout his career, Scott has collaborated with talented professionals, including Neha J. Parikh and Anirban Roy. These collaborations have contributed to the advancement of technology in the field of medication delivery systems.

Conclusion

Scott W. Lee's contributions to fluid delivery systems, particularly in insulin management, showcase his dedication to improving healthcare technology. His innovative patents reflect a commitment to enhancing the lives of individuals who rely on insulin delivery devices.